218 related articles for article (PubMed ID: 34210686)
21. Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck.
Sanz-Garcia E; Zou J; Avery L; Spreafico A; Waldron J; Goldstein D; Hansen A; Cho BCJ; de Almeida J; Hope A; Hosni A; Hahn E; Perez-Ordonez B; Zhao Z; Smith C; Zheng Y; Singaravelan N; Bratman SV; Siu LL
Cell Death Differ; 2024 Apr; 31(4):460-468. PubMed ID: 38409276
[TBL] [Abstract][Full Text] [Related]
22. Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal study.
Constandinou-Williams C; Collins SI; Roberts S; Young LS; Woodman CB; Murray PG
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):832-7. PubMed ID: 20200441
[TBL] [Abstract][Full Text] [Related]
23. The Diagnostic Value of Circulating Cell-Free HPV DNA in Plasma from Cervical Cancer Patients.
Bønløkke S; Stougaard M; Sorensen BS; Booth BB; Høgdall E; Nyvang GB; Lindegaard JC; Blaakær J; Bertelsen J; Fuglsang K; Strube ML; Lenz S; Steiniche T
Cells; 2022 Jul; 11(14):. PubMed ID: 35883612
[TBL] [Abstract][Full Text] [Related]
24. Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial.
Bernard-Tessier A; Jeannot E; Guenat D; Debernardi A; Michel M; Proudhon C; Vincent-Salomon A; Bièche I; Pierga JY; Buecher B; Meurisse A; François É; Cohen R; Jary M; Vendrely V; Samalin E; El Hajbi F; Baba-Hamed N; Borg C; Bidard FC; Kim S
Clin Cancer Res; 2019 Apr; 25(7):2109-2115. PubMed ID: 30504426
[TBL] [Abstract][Full Text] [Related]
25. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
26. Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma.
Bhambhani C; Sandford E; Haring CT; Brummel C; Tuck KL; Olesnavich M; Bhangale AD; Walline HM; Dermody SM; Spector ME; Chinn SB; Casper K; Mierzwa M; Swiecicki PL; Chad Brenner J; Tewari M
Oral Oncol; 2023 Aug; 143():106436. PubMed ID: 37269557
[TBL] [Abstract][Full Text] [Related]
27. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus DNA in plasma of patients with cervical cancer.
Pornthanakasem W; Shotelersuk K; Termrungruanglert W; Voravud N; Niruthisard S; Mutirangura A
BMC Cancer; 2001; 1():2. PubMed ID: 11244579
[TBL] [Abstract][Full Text] [Related]
29. Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients.
Ho CM; Yang SS; Chien TY; Huang SH; Jeng CJ; Chang SF
Gynecol Oncol; 2005 Dec; 99(3):615-21. PubMed ID: 16099020
[TBL] [Abstract][Full Text] [Related]
30. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
[TBL] [Abstract][Full Text] [Related]
31. HPV transcript expression affects cervical cancer response to chemoradiation.
Ruiz FJ; Inkman M; Rashmi R; Muhammad N; Gabriel N; Miller CA; McLellan MD; Goldstein M; Markovina S; Grigsby PW; Zhang J; Schwarz JK
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34255749
[TBL] [Abstract][Full Text] [Related]
32. An association between human papillomavirus 16/18 deoxyribonucleic acid in peripheral blood with p16 protein expression in neoplastic cervical lesions.
Tsai HJ; Peng YW; Lin LY; Chou MC; Lee H; Chiou HL
Cancer Detect Prev; 2005; 29(6):537-43. PubMed ID: 16289504
[TBL] [Abstract][Full Text] [Related]
33. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
[TBL] [Abstract][Full Text] [Related]
35. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
[TBL] [Abstract][Full Text] [Related]
36. HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.
Duvlis S; Popovska-Jankovic K; Arsova ZS; Memeti S; Popeska Z; Plaseska-Karanfilska D
J Med Virol; 2015 Sep; 87(9):1578-86. PubMed ID: 25880030
[TBL] [Abstract][Full Text] [Related]
37. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
[TBL] [Abstract][Full Text] [Related]
38. Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer.
Garcia-Murillas I; Chopra N; Comino-Méndez I; Beaney M; Tovey H; Cutts RJ; Swift C; Kriplani D; Afentakis M; Hrebien S; Walsh-Crestani G; Barry P; Johnston SRD; Ring A; Bliss J; Russell S; Evans A; Skene A; Wheatley D; Dowsett M; Smith IE; Turner NC
JAMA Oncol; 2019 Oct; 5(10):1473-1478. PubMed ID: 31369045
[TBL] [Abstract][Full Text] [Related]
39. Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV-associated cancers; a meta-analysis on recurrent event endpoints.
Karimi A; Jafari-Koshki T; Zehtabi M; Kargar F; Gheit T
Cancer Med; 2023 Sep; 12(17):17592-17602. PubMed ID: 37492996
[TBL] [Abstract][Full Text] [Related]
40. Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.
Mahantshetty U; Teni T; Naga P; Hotwani C; Umesh S; Kannan S; Hande V; Pawar S; Engineer R; Chopra S; Deodhar K; Maheshwari A; Gurram L; Gupta S; Shrivastava SK
Gynecol Oncol; 2018 Feb; 148(2):299-304. PubMed ID: 29203175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
